NIAID Banner Logo Image

Opportunistic Infections Citation List: March 1 - March 14, 2013

ANTIFUNGAL COMPOUNDS (includes Cryptococcus, Aspergillus, Candida, & Histoplasma)

1. Inhibitory Effects of Olea ferruginea Crude Leaves Extract against Some Bacterial and Fungal Pathogen. Amin, A., M.A. Khan, S. Shah, M. Ahmad, M. Zafar, and A. Hameed. Pakistan Journal of Pharmaceutical Sciences, 2013. 26(2): p. 251-254. PMID[23455192].

[PubMed]. OI_0301-031413.


2. Homoisocitrate Dehydrogenase from Candida albicans: Properties, Inhibition, and Targeting by an Antifungal Pro-Drug. Gabriel, I., N.D. Vetter, D.R. Palmer, M.J. Milewska, M. Wojciechowski, and S. Milewski. FEMS Yeast Research, 2013. 13(2): p. 143-155. PMID[23107040].

[PubMed]. OI_0301-031413.


3. Chitosan-thioglycolic acid as a Versatile Antimicrobial Agent. Geisberger, G., E.B. Gyenge, D. Hinger, A. Kach, C. Maake, and G.R. Patzke. Biomacromolecules, 2013. [Epub ahead of print]. PMID[23470196].

[PubMed]. OI_0301-031413.


4. Synthesis, Antibacterial and Antifungal Activity of Some New Pyrazoline and Pyrazole Derivatives. Hassan, S.Y. Molecules, 2013. 18(3): p. 2683-2711. PMID[23449067].

[PubMed]. OI_0301-031413.


5. Rapid Microwave Assisted Synthesis and Antimicrobial Bioevaluation of Novel Steroidal Chalcones. Kakati, D., R.K. Sarma, R. Saikia, N.C. Barua, and J.C. Sarma. Steroids, 2013. 78(3): p. 321-326. PMID[23287649].

[PubMed]. OI_0301-031413.


6. Anthelmintic and Antimicrobial Activity of Methanolic and Aqueous Extracts of Euphorbia helioscopia L. Lone, B.A., S.A. Bandh, M.Z. Chishti, F.A. Bhat, H. Tak, and H. Nisa. Tropical Animal Health and Production, 2013. 45(3): p. 743-749. PMID[23065392].

[PubMed]. OI_0301-031413.


7. Copper(II) Triflate Promoted Multicomponent Catalytic Clubbing of Piperazinyl-thiazoloquinolines and Thiazolocoumarins as Antimicrobials. Patel, R.V., J.K. Patel, S.H. Nile, and S.W. Park. Archiv der Pharmazie, 2013. 346(3): p. 221-231. PMID[23423648].

[PubMed]. OI_0301-031413.


8. Identification and Evaluation of Novel Acetolactate Synthase Inhibitors as Antifungal Agents. Richie, D.L., K.V. Thompson, C. Studer, V. Prindle, T. Aust, R. Riedl, D. Estoppey, J. Tao, J.A. Sexton, T. Zabawa, J. Drumm, S. Cotesta, J. Eichenberger, S. Schuierer, N. Hartmann, N.R. Movva, J.A. Tallarico, N.S. Ryder, and D. Hoepfner. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23478965].

[PubMed]. OI_0301-031413.


9. MIC Values of Voriconazole Are Predictive of Treatment Results in Murine Infections by Aspergillus terreus Species Complex. Salas, V., F.J. Pastor, D.A. Sutton, E. Calvo, E. Mayayo, A.W. Fothergill, M.G. Rinaldi, and J. Guarro. Antimicrobial Agents and Chemotherapy, 2013. 57(3): p. 1532-1534. PMID[23295929].

[PubMed]. OI_0301-031413.


10. New Water-soluble Polypyridine Silver(I) Derivatives of 1,3,5-Triaza-7-phosphaadamantane (PTA) with Significant Antimicrobial and Antiproliferative Activities. Smolenski, P., S.W. Jaros, C. Pettinari, G. Lupidi, L. Quassinti, M. Bramucci, L.A. Vitali, D. Petrelli, A. Kochel, and A.M. Kirillov. Dalton Transactions, 2013. [Epub ahead of print]. PMID[23474654].

[PubMed]. OI_0301-031413.


11. Mechanism of Action of Efinaconazole, a Novel Triazole Antifungal Agent. Tatsumi, Y., M. Nagashima, T. Shibanushi, A. Iwata, Y. Kangawa, F. Inui, W.J. Jo Siu, R. Pillai, and Y. Nishiyama. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23459486].

[PubMed]. OI_0301-031413.


12. Isolation and Characterization of New p-Terphenyls with Antifungal, Antibacterial, and Antioxidant Activities from Halophilic Actinomycete Nocardiopsis gilva Yim 90087. Tian, S.Z., X. Pu, G. Luo, L.X. Zhao, L.H. Xu, W.J. Li, and Y. Luo. Journal of Agricultural and Food Chemistry, 2013. [Epub ahead of print]. PMID[23441911].

[PubMed]. OI_0301-031413.


13. Identification and Characterization of Antifungal Active Substances of Streptomyces hygroscopicus BS-112. Zhang, N., Z. Song, Y. Xie, P. Cui, H. Jiang, T. Yang, R. Ju, Y. Zhao, J. Li, and X. Liu. World Journal of Microbiology & Biotechnology, 2013. [Epub ahead of print]. PMID[23468248].

[PubMed]. OI_0301-031413.

ANTIBACTERIAL COMPOUNDS (includes Mycobacterium spp., Drug Resistant, MAC, MDR)

14. Posaconazole Exhibits in Vitro and in Vivo Synergistic Antifungal Activity with Caspofungin or FK506 against Candida albicans. Chen, Y.L., V.N. Lehman, A.F. Averette, J.R. Perfect, and J. Heitman. Plos One, 2013. 8(3): p. e57672. PMID[23472097].

[PubMed]. OI_0301-031413.


15. Preliminary Pharmacokinetic Study of Repeated Doses of Rifampin and Rifapentine in Guinea Pigs. Dutta, N.K., A. Alsultan, C.A. Peloquin, and P.C. Karakousis. Antimicrobial Agents and Chemotherapy, 2013. 57(3): p. 1535-1537. PMID[23295923].

[PubMed]. OI_0301-031413.


16. Thioridazine Lacks Bactericidal Activity in an Animal Model of Extracellular Tuberculosis. Dutta, N.K., M.L. Pinn, M. Zhao, M.A. Rudek, and P.C. Karakousis. The Journal of Antimicrobial Chemotherapy, 2013. [Epub ahead of print]. PMID[23463208].

[PubMed]. OI_0301-031413.


17. Boron-containing Peptidomimetics - a Novel Class of Selective Anti-tubercular Drugs. Gorovoy, A.S., O.V. Gozhina, J.S. Svendsen, A.A. Domorad, G.V. Tetz, V.V. Tetz, and T. Lejon. Chemical Biology & Drug Design, 2013. 81(3): p. 408-413. PMID[23164166].

[PubMed]. OI_0301-031413.


18. Discovery of Novel Inhibitors Targeting the Mycobacterium tuberculosis O-acetylserine Sulfhydrylase (CysK1) Using Virtual High-throughput Screening. Jean Kumar, V.U., O. Poyraz, S. Saxena, R. Schnell, P. Yogeeswari, G. Schneider, and D. Sriram. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1182-1186. PMID[23391589].

[PubMed]. OI_0301-031413.


19. Aromatic Polyketides from a Sponge-derived Fungus Metarhizium Anisopliae mxh-99 and Their Antitubercular Activities. Kong, X., X. Ma, Y. Xie, S. Cai, T. Zhu, Q. Gu, and D. Li. Archives of Pharmacal Research, 2013. [Epub ahead of print]. PMID[23463335].

[PubMed]. OI_0301-031413.


20. Antimycobacterial Activity Evaluation, Time-kill Kinetic and 3d-Qsar Study of C-(3-Aminomethyl-cyclohexyl)-methylamine Derivatives. Kumar, D., K.K. Raj, M. Bailey, T. Alling, T. Parish, and D.S. Rawat. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1365-1369. PMID[23357633]. [PubMed]. OI_0301-031413.


21. Discovery of Novel InhA Reductase Inhibitors: Application of Pharmacophore- and Shape-based Screening Approach. Kumar, U.C., S.K. Bvs, S. Mahmood, S. D, P. Kumar-Sahu, S. Pulakanam, L. Ballell, D. Alvarez-Gomez, S. Malik, and S. Jarp. Future Medicinal Chemistry, 2013. 5(3): p. 249-259. PMID[23464516].

[PubMed]. OI_0301-031413.


22. Zanthoxylum Capense Constituents with Antimycobacterial Activity against Mycobacterium tuberculosis in Vitro and ex Vivo within Human Macrophages. Luo, X., D. Pires, J.A. Ainsa, B. Gracia, N. Duarte, S. Mulhovo, E. Anes, and M.J. Ferreira. Journal of Ethnopharmacology, 2013. 146(1): p. 417-422. PMID[23337743].

[PubMed]. OI_0301-031413.


23. Studies of Inositol 1-Phosphate Analogues as Inhibitors of the Phosphatidylinositol Phosphate Synthase in Mycobacteria. Morii, H., T. Okauchi, H. Nomiya, M. Ogawa, K. Fukuda, and H. Taniguchi. Journal of Biochemistry, 2013. 153(3): p. 257-266. PMID[23225597].

[PubMed]. OI_0301-031413.


24. Synthesis and Antitubercular Activity of Amino Alcohol Fused Spirochromone Conjugates. Mujahid, M., R.G. Gonnade, P. Yogeeswari, D. Sriram, and M. Muthukrishnan. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1416-1419. PMID[23357635].

[PubMed]. OI_0301-031413.


25. Targeting Mycobacterium tuberculosis and Other Microbial Pathogens Using Improved Synthetic Antibacterial Peptides. Ramon-Garcia, S., R. Mikut, C. Ng, S. Ruden, R. Volkmer, M. Reischl, K. Hilpert, and C.J. Thompson. Antimicrobial Agents and Chemotherapy, 2013. [Epub ahead of print]. PMID[23478953].

[PubMed]. OI_0301-031413.


26. Anti-tuberculosis Neolignans from Piper regnellii. Scodro, R.B., C.T. Pires, V.S. Carrara, C.O. Lemos, L. Cardozo-Filho, V.A. Souza, A.G. Correa, V.L. Siqueira, M.V. Lonardoni, R.F. Cardoso, and D.A. Cortez. Phytomedicine, 2013. [Epub ahead of print]. PMID[23474218].

[PubMed]. OI_0301-031413.


27. A Facile Three-component [3+2]-cycloaddition for the Regioselective Synthesis of Highly Functionalised Dispiropyrrolidines Acting as Antimycobacterial Agents. Wei, A.C., M.A. Ali, Y.K. Yoon, R. Ismail, T.S. Choon, and R.S. Kumar. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1383-1386. PMID[23352268].

[PubMed]. OI_0301-031413.


28. Synthesis of Novel Spirooxindolo-pyrrolidines, Pyrrolizidines, and Pyrrolothiazoles Via a Regioselective Three-component [3+2] cycloaddition and Their Preliminary Antimicrobial Evaluation. Wu, G., L. Ouyang, J. Liu, S. Zeng, W. Huang, B. Han, F. Wu, G. He, and M. Xiang. Molecular Diversity, 2013. [Epub ahead of print]. PMID[23467917].

[PubMed]. OI_0301-031413.


29. 3H-1,2,4-dithiazol-3-one Compounds as Novel Potential Affordable Antitubercular Agents. Yang, J., W. Pi, L. Xiong, W. Ang, T. Yang, J. He, Y. Liu, Y. Chang, W. Ye, Z. Wang, Y. Luo, and Y. Wei. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1424-1427. PMID[23337602].

[PubMed]. OI_0301-031413.

ANTIMALARIAL COMPOUNDS (Plasmodium spp.)

30. Anti-malarial Activity of New N-Acetyl-L-leucyl-L-leucyl-L-norleucinal (ALLN) Derivatives against Plasmodium falciparum. Choi, H.J., M. Cui, D.Y. Li, H.O. Song, H.S. Kim, and H. Park. Bioorganic & Medicinal Chemistry Letters, 2013. 23(5): p. 1293-1296. PMID[23357632].

[PubMed]. OI_0301-031413.


31. Antimalarial Activities of 6-Iodouridine and Its Prodrugs and Potential for Combination Therapy. Crandall, I.E., E. Wasilewski, A.M. Bello, A. Mohmmed, P. Malhotra, E.F. Pai, K.C. Kain, and L.P. Kotra. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23410043].

[PubMed]. OI_0301-031413.


32. Selective Inhibition of an Apicoplastic Aminoacyl-tRNA Synthetase from Plasmodium falciparum. Hoen, R., E.M. Novoa, A. Lopez, N. Camacho, L. Cubells, P. Vieira, M. Santos, P. Marin-Garcia, J.M. Bautista, A. Cortes, L. Ribas de Pouplana, and M. Royo. ChemBioChem, 2013. 14(4): p. 499-509. PMID[23444099].

[PubMed]. OI_0301-031413.


33. Acyclic Nucleoside Phosphonates Containing a Second Phosphonate Group Are Potent Inhibitors of 6-Oxopurine phosphoribosyltransferases and Have Antimalarial Activity. Keough, D.T., P. Spacek, D. Hockova, T. Tichy, S. Vrbkova, L. Slavetinska, Z. Janeba, L. Naesens, M.D. Edstein, M. Chavchich, T.H. Wang, J.D. Jersey, and L.W. Guddat. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23448281].

[PubMed]. OI_0301-031413.


34. Antimalarial Interaction of Quinine and Quinidine with Clarithromycin. Pandey, S.K., H. Dwivedi, S. Singh, W.A. Siddiqui, and R. Tripathi. Parasitology, 2013. 140(3): p. 406-413. PMID[23137860].

[PubMed]. OI_0301-031413.

ANTIPROTOZOAL COMPOUNDS

35. Optimizing Small Molecule Inhibitors of Calcium-dependent Protein Kinase 1 to Prevent Infection by Toxoplasma gondii. Lourido, S., C. Zhang, M. Lopez, K. Tang, J. Barks, Q. Wang, S.A. Wildman, K. Shokat, and L.D. Sibley. Journal of Medicinal Chemistry, 2013. [Epub ahead of print]. PMID[23470217].

[PubMed]. OI_0301-031413.


36. Toxoplasma gondii: The Effect of Fluconazole Combined with Sulfadiazine and Pyrimethamine against Acute Toxoplasmosis in Murine Model. Martins-Duarte, E.S., W. de Souza, and R.C. Vommaro. Experimental Parasitology, 2013. 133(3): p. 294-299. PMID[23270807].

[PubMed]. OI_0301-031413.

Citations from the ISI Web of Knowledge Listings for O.I.

37. Quinolone Derivatives as Antitubercular Drugs. Asif, M., A.A. Siddiqui, and A. Husain. Medicinal Chemistry Research, 2013. 22(3): p. 1029-1042. ISI[000314283500001].

[WOS]. OI_0301-031413.


38. Synthesis and Biological Evaluation of Novel Benzoquinones as Potential Antimicrobial Agents. Chaaban, I., E.M. El Khawass, M.A. Mahran, H.A. Abd El Razik, N.S. El Salamouni, and A.E.A. Wahab. Medicinal Chemistry Research, 2013. 22(2): p. 841-851. ISI[000313711700031].

[WOS]. OI_0301-031413.


39. Synthesis, Structure-Activity Relationships (SAR) and in Silico Studies of Coumarin Derivatives with Antifungal Activity. de Araujo, R.S.A., F.Q.S. Guerra, E.D. Lima, C.A. de Simone, J.F. Tavares, L. Scotti, M.T. Scotti, T.M. de Aquino, R.O. de Moura, F.J.B. Mendonca, and J.M. Barbosa. International Journal of Molecular Sciences, 2013. 14(1): p. 1293-1309. ISI[000314048800075].

[WOS]. OI_0301-031413.


40. Synthesis of Promising Antimicrobial Agents: A Novel Series of N-(4-(2,6-dichloroquinolin-3-yl)-6-(aryl)pyrimidin-2-yl)-2-morpholinoace tamides. Desai, N.C., K.M. Rajpara, V.V. Joshi, H.V. Vaghani, and H.M. Satodiya. Medicinal Chemistry Research, 2013. 22(3): p. 1172-1183. ISI[000314283500015].

[WOS]. OI_0301-031413.


41. Synthesis of New 4-(2,5-Dimethylpyrrol-1-yl)/4-pyrrol-1-yl benzoic acid Hydrazide Analogs and Some Derived Oxadiazole, Triazole and Pyrrole Ring Systems: A Novel Class of Potential Antibacterial, Antifungal and Antitubercular Agents. Joshi, S.D., Y. More, H.M. Vagdevi, V.P. Vaidya, G.S. Gadaginamath, and V.H. Kulkarni. Medicinal Chemistry Research, 2013. 22(3): p. 1073-1089. ISI[000314283500006].

[WOS]. OI_0301-031413.


42. Synthesis and Antimicrobial Activity of Coumarin Pyrazole Pyrimidine 2,4,6(1H,3H,5H)Triones and Thioxopyrimidine4,6(1H,5H)diones. Laxmi, S.V., B.S. Kuarm, and B. Rajitha. Medicinal Chemistry Research, 2013. 22(2): p. 768-774. ISI[000313711700024].

[WOS]. OI_0301-031413.


43. Quinoline-based Azetidinone and Thiazolidinone Analogues as Antimicrobial and Antituberculosis Agents. Mistry, B.M. and S. Jauhari. Medicinal Chemistry Research, 2013. 22(2): p. 647-658. ISI[000313711700013].

[WOS]. OI_0301-031413.


44. Antibacterial and Antifungal Activities of Crude Plant Extracts from Colombian Biodiversity.. Nino, J., O.M. Mosquera, and Y.M. Correa. Revista de Biologia Tropical, 2012. 60(4): p. 1535-1542. ISI[000314444200011].

[WOS]. OI_0301-031413.


45. Anti-HIV, Antimycobacterial and Antimicrobial Studies of Newly Synthesized 1,2,4-Triazole clubbed benzothiazoles. Patel, N.B., I.H. Khan, C. Pannecouque, and E. De Clercq. Medicinal Chemistry Research, 2013. 22(3): p. 1320-1329. ISI[000314283500030].

[WOS]. OI_0301-031413.


46. Design, Synthesis and Molecular Modelling of Novel 4-Thiazolidinones of Potential Activity against Gram Positive Bacteria. Radwan, A.A. Medicinal Chemistry Research, 2013. 22(3): p. 1131-1141. ISI[000314283500011].

[WOS]. OI_0301-031413.


47. Design and Synthesis of Positional Isomers of 1-Alkyl-2-trifluoromethyl-5 or 6-substituted benzimidazoles and Their Antimicrobial Activity. Sathaiah, G., A.R. Kumar, A.C. Shekhar, K. Raju, P.S. Rao, B. Narsaiah, A.R. Reddy, D. Lakshmi, and B. Sridhar. Medicinal Chemistry Research, 2013. 22(3): p. 1229-1237. ISI[000314283500021].

[WOS]. OI_0301-031413.


48. Potent Activity against Multidrug-resistant Mycobacterium tuberculosis of alpha-Mangostin Analogs. Sudta, P., P. Jiarawapi, A. Suksamrarn, P. Hongmanee, and S. Suksamrarn. Chemical & Pharmaceutical Bulletin, 2013. 61(2): p. 194-203. ISI[000314383100011].

[WOS]. OI_0301-031413.


49. Structure-Activity Relationships of Tetrahydrocarbazole Derivatives as Antifungal Lead Compounds. Wang, W.Y., G.Q. Dong, J.L. Gu, Y.Q. Zhang, S.Z. Wang, S.P. Zhu, Y. Liu, Z.Y. Miao, J.Z. Yao, W.N.A. Zhang, and C.Q. Sheng. MedChemComm, 2013. 4(2): p. 353-362. ISI[000314311600008].

[WOS]. OI_0301-031413.


50. Evaluation of the Anticryptococcal Activity of the Antibiotic Polymyxin B in Vitro and in Vivo. Zhai, B. and X.R. Lin. International Journal of Antimicrobial Agents, 2013. 41(3): p. 250-254. ISI[000314630100007].

[WOS]. OI_0301-031413.


If using ChemDB information for publication or abstract presentation, please cite the website in addition to the original information source.    Database last updated: September 2022